CYB561 and cancer: Knocking down CYB561 in the NEPC cell model PC-3 decreased the expression of NED markers and secretion of growth-promoting factors, lowered the intracellular Fe2+concentration, affected IRG expression, and reduced overall aggressive cancer cell behavior based on several cancer hallmarks.